CLINICAL TRIAL / NCT03585660
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
- Interventional
- Recruiting
- NCT03585660
Contact Information
MRI Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).